MRGG Inhibitors
MRGG inhibitors encompass a diverse group of chemical compounds that can indirectly influence the activity of MRGG by targeting various signaling pathways and cellular processes in which MRGG is involved. The actions of these inhibitors would lead to the reduced functional activity of MRGG through specific interference with its regulation or activation mechanisms.
Staurosporine, as a kinase inhibitor, has the potential to inhibit MRGG by preventing the phosphorylation of proteins that could be involved in its regulation. This is because the activity of MRGG could be contingent upon phosphorylation events mediated by kinases, which Staurosporine can inhibit. Src family kinases, which can be inhibited by compounds like PP2 and SU6656, play a pivotal role in numerous cellular signaling pathways that can influence the function of proteins like MRGG. The inhibition of these kinases can lead to the deactivation of MRGG by disrupting the phosphorylation and activation of proteins that are upstream or regulatory to MRGG. Similarly, the PI3K pathway, targeted by LY294002 and Wortmannin, is crucial for multiple cellular functions, including the activation of downstream proteins. By inhibiting PI3K, these compounds can impede the activation of signaling cascades that might otherwise culminate in the activation of MRGG.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine inhibits protein kinase C (PKC) which can reduce the phosphorylation of many substrates, including MPZL3. Reduced phosphorylation of MPZL3 would likely diminish its functional activity as phosphorylation is often crucial for protein function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Since Src kinases can phosphorylate tyrosine residues and potentially activate downstream proteins like MPZL3, PP2 inhibition of Src kinases can lead to reduced activation of MPZL3. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K activation is part of a pathway that can lead to the activation of proteins like MPZL3. By inhibiting PI3K, LY294002 can prevent the activation of MPZL3 thereby reducing its functional activity. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Dasatinib is a broad-spectrum tyrosine kinase inhibitor, which can inhibit the activation of downstream proteins that rely on tyrosine phosphorylation such as MPZL3, thereby reducing its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which is involved in cell growth and proliferation pathways that may regulate proteins like MPZL3. Inhibition of mTOR by Rapamycin can lead to decreased function of MPZL3. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor which prevents the activation of ERK, a kinase that could phosphorylate substrates like MPZL3. By inhibiting MEK, U0126 can lead to a reduction in MPZL3 functional activity through decreased phosphorylation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, SB203580 can reduce the phosphorylation of proteins involved in inflammatory responses, potentially including MPZL3, leading to its decreased activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which phosphorylates substrates involved in apoptosis and other cell processes. By inhibiting JNK, SP600125 can reduce the functional activity of proteins like MPZL3 that may be regulated by JNK activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can prevent the activation of ERK pathway. Since MPZL3 might be activated by ERK-mediated phosphorylation, inhibition by PD98059 can result in decreased MPZL3 activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor similar to LY294002. By inhibiting PI3K, Wortmannin can reduce the activation of downstream proteins like MPZL3, leading to a decrease in its functional activity. | ||||||